A carregar...
Safe Integration of Nelarabine into Intensive Chemotherapy in Newly Diagnosed T-cell Acute Lymphoblastic Leukemia: Children’s Oncology Group Study AALL0434
BACKGROUND: Nelarabine has shown impressive single agent clinical activity in T-cell acute lymphoblastic leukemia (T-ALL), but has been associated with significant neurotoxicities in heavily pre-treated patients. We showed previously that it was safe to add nelarabine to a BFM-86 chemotherapy backbo...
Na minha lista:
Publicado no: | Pediatr Blood Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4433576/ https://ncbi.nlm.nih.gov/pubmed/25755211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25470 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|